Omeros Shares Surge 14% on Q4 Earnings Beat with Novo Nordisk Partnership

miércoles, 1 de abril de 2026, 2:11 pm ET1 min de lectura
NVO--
OMER--

Omeros Corporation's shares rose 14% as the company reported better-than-expected Q4 2025 financials, driven by a partnership with Novo Nordisk. The biotech's earnings beat expectations, boosting its stock to its best intraday gain since December.

Omeros Shares Surge 14% on Q4 Earnings Beat with Novo Nordisk Partnership

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios